LAMPIS, SILVIA
 Distribuzione geografica
Continente #
EU - Europa 536
NA - Nord America 138
AS - Asia 48
AF - Africa 8
Totale 730
Nazione #
IT - Italia 436
US - Stati Uniti d'America 136
SG - Singapore 25
CH - Svizzera 20
DE - Germania 14
SE - Svezia 12
CN - Cina 10
FI - Finlandia 10
GB - Regno Unito 9
IE - Irlanda 8
NL - Olanda 7
CI - Costa d'Avorio 6
PT - Portogallo 6
BD - Bangladesh 5
ES - Italia 4
ID - Indonesia 4
IN - India 4
FR - Francia 3
RU - Federazione Russa 3
BE - Belgio 2
BG - Bulgaria 2
TG - Togo 2
CA - Canada 1
GL - Groenlandia 1
Totale 730
Città #
Parma 199
Bologna 49
Singapore 24
Reggio Emilia 23
Chandler 18
Redmond 17
Milan 15
Bern 14
Fairfield 14
Santa Clara 13
Rome 11
San Giuliano Milanese 10
Ashburn 9
Turin 9
Helsinki 8
Dublin 7
Abidjan 6
Princeton 6
Southend 6
Boardman 5
Dhaka 5
San Felice sul Panaro 5
Seattle 5
Jakarta 4
Berlin 3
Cambridge 3
Formigine 3
Houston 3
Nardò 3
San Diego 3
Woodbridge 3
Amsterdam 2
Ann Arbor 2
Beijing 2
Bollate 2
Casalmaiocco 2
Des Moines 2
Florence 2
Forlì 2
Jesolo 2
Lappeenranta 2
Lomé 2
London 2
Los Angeles 2
Madrid 2
Mülheim 2
Padova 2
Putignano 2
Sofia 2
Taglio Di Po 2
Teià 2
Wilmington 2
Bremen 1
Brussels 1
Bünde 1
Castellarano 1
Cesena 1
Chicago 1
Cisterna di Latina 1
Citta 1
Clonee 1
Dübendorf 1
Edinburgh 1
Engersch 1
Foligno 1
Formia 1
Frankfurt am Main 1
Frattamaggiore 1
Galliera Veneta 1
Guesnain 1
Hangzhou 1
Lecce 1
Medford 1
Moscow 1
Nuuk 1
Paris 1
Roccapiemonte 1
San Pietro in Casale 1
Segrate 1
Shanghai 1
Toronto 1
Trento 1
Verona 1
Washington 1
Westminster 1
Zola Predosa 1
Totale 579
Nome #
Antigene MYCN Silencing by BGA002 Inhibits SCLC Progression Blocking mTOR Pathway and Overcomes Multidrug Resistance 335
A novel MYCN-specific antigene oligonucleotide deregulates mitochondria and inhibits tumor growth in MYCN-amplified neuroblastoma 158
The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma 147
MYCN Drives a Tumor Immunosuppressive Environment Which Impacts Survival in Neuroblastoma 65
MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment 44
Totale 749
Categoria #
all - tutte 2.192
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.192


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202027 0 0 0 0 0 0 10 5 6 3 3 0
2020/202134 7 0 2 3 3 1 5 1 5 3 2 2
2021/202294 2 3 4 3 5 6 5 8 8 2 12 36
2022/2023192 10 18 4 7 9 5 17 12 24 26 31 29
2023/2024170 18 10 8 9 2 11 5 9 8 29 22 39
2024/2025232 28 37 77 49 24 17 0 0 0 0 0 0
Totale 749